Cost and outcomes of the ultrasound screening program for birth defects over time: a population-based study in France

BMJ Open
Clément FerrierIsabelle Durand-Zaleski

Abstract

To assess trends in the average costs and effectiveness of the French ultrasound screening programme for birth defects. A population-based study. National Public Health Insurance claim database. All pregnant women in the 'Echantillon Généraliste des Bénéficiaires', a permanent representative sample of 1/97 of the individuals covered by the French Health Insurance System. Trends in the costs and in the average cost-effectiveness ratio (ACER) of the screening programme (in € per case detected antenatally), per year, between 2006 and 2014. incremental cost-effectiveness ratio (ICER) from 1 year to another were also estimated. We assessed costs related to the ultrasound screening programme of birth defects excluding the specific screening of Down's syndrome. The outcome for effectiveness was the prenatal detection rate of birth defects, assessed in a previous study. Linear and logistic regressions were used to analyse time trends. During the study period, there was a slight decrease in prenatal detection rates (from 58.2% in 2006 to 55.2% in 2014; p=0.015). The cost of ultrasound screening increased from €168 in 2006 to €258 per pregnancy in 2014 (p=0.001). We found a 61% increase in the ACER for ultrasound screening during the stu...Continue Reading

References

Jul 29, 1993·The New England Journal of Medicine·L B Russell
May 1, 1996·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·T LeivoO P Heinonen
May 12, 1998·Journal of Medical Screening·G Long, A Sprigg
Feb 24, 2001·Acta Obstetricia Et Gynecologica Scandinavica·E Garne, UNKNOWN Eurocat Working Group
Sep 29, 2001·Obstetrics and Gynecology·K LeeR L Mittendorf
Nov 2, 2004·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·F VanaraT Todros
Oct 25, 2007·Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine·Yasuko YamamuraKirk D Ramin
Feb 15, 2008·The New England Journal of Medicine·Joshua T CohenMilton C Weinstein
Nov 4, 2008·Journal of Pediatric Urology·Ester GarneUNKNOWN Eurocat Working Group
Jul 28, 2010·Journal of Medical Screening·Ester GarneUNKNOWN EUROCAT
Aug 26, 2010·European Journal of Human Genetics : EJHG·Patricia Anne BoydUNKNOWN EUROCAT working group
Feb 11, 2011·The New England Journal of Medicine·N Scott AdzickUNKNOWN MOMS Investigators
Mar 4, 2011·Journal of Neuroradiology. Journal De Neuroradiologie·UNKNOWN Société Française de NeuroradiologieUNKNOWN Agence de la Biomédecine
Mar 9, 2011·Birth Defects Research. Part A, Clinical and Molecular Teratology·Patricia A BoydHelen Dolk
Dec 2, 2011·BJOG : an International Journal of Obstetrics and Gynaecology·M GisslerUNKNOWN REPROSTAT group
Jan 17, 2012·Archives of Disease in Childhood·Rikke Neess PedersenUNKNOWN EUROCAT Working group
Sep 4, 2012·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·N LelongB Khoshnood
May 26, 2017·Pharmacoepidemiology and Drug Safety·Julien BezinNicholas Moore
Jul 20, 2017·Gynécologie, Obstétrique, Fertilité & Sénologie·C FerrierJ-M Jouannic

❮ Previous
Next ❯

Software Mentioned

Stata
EUROCAT

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.